Two pharmacy interventions to improve refill persistence for chronic disease medications a randomized, controlled trial

Medical Care

Volumn 47, Issue 1, 2009, Pages 32-40

  Nietert, Paul J ^a   Tilley, Barbara C ^a   Zhao, Wenle ^a   Edwards, Peter F ^b   Wessell, Andrea M ^b   Mauldin, Patrick D ^b,c   Polk, Pam P ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d Piggly Wiggly Carolina Company Inc   (United States)

Author keywords

Chronic disease; Community pharmacy services; Patient compliance; Randomized controlled trial

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PHARMACY; PHYSICIAN; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; TELEPHONE; UNITED STATES;

ADULT; AGED; CHRONIC DISEASE; CLINICAL PHARMACY INFORMATION SYSTEMS; DIRECTIVE COUNSELING; DRUG UTILIZATION; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MEDICAID; MEDICATION ADHERENCE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACIES; PROGRAM EVALUATION; PROPORTIONAL HAZARDS MODELS; REMINDER SYSTEMS; SOCIOECONOMIC FACTORS; SOUTH CAROLINA; TELEFACSIMILE; TELEPHONE; TIME FACTORS; UNITED STATES;

EID: 58449119395     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181808c17     Document Type: Article

References (36)

1. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383-386.
2. Mohler ER III, Delanty N, Rader DJ, et al. Statins and cerebrovascular disease: plaque attack to prevent brain attack. Vasc Med. 1999;4:269-272.
3. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296: 2563-2571.
4. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015-1021.
5. Peterson GM, McLean S, Senator GB. Determinants of patient compliance, control, presence of complications, and handicap in non-insulin-dependent diabetes. Aust N Z J Med. 1984;14:135-141.
6. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150:841-845.
7. Grimm RH Jr, Grandits GA, Cutler JA, et al. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the treatment of Mild Hypertension Study. Arch Intern Med. 1997;157:638-648.
8. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated heatlh care costs in an older population with Type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25:2958-2971.
9. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
10. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence [review]. Cochrane Database Syst Rev. 2008;16: CD000011.
11. Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Phar-macoepidemiol Drug Saf. 2006;15:565-574.
12. Schectman JM, Bovbjerg VE, Voss JD. Predictors of medication-refill adherence in an indigent rural population. Med Care. 2002;40: 1294-1300.
13. Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929-2933.
14. Jackson JE, Doescher MP, Saver BG, et al. Prescription drug coverage, health, and medication acquisition among seniors with one or more chronic conditions. Med Care. 2004;42:1056-1065.
15. Piette JD, Heisler M, Ganoczy D, et al. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension. Psychiatric Serv. 2007;58:207-212.
16. Morningstar BA, Sketris IS, Kephart GC, et al. Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycae-mic drug therapy in seniors in Nova Scotia, Canada. J Clin Pharm Ther. 2002;27:213-220.
17. Osterberg L, Blaschke T. Adherence to medication. New Engl J Med. 2005;353:487-497.
18. Gross R, Zhang Y, Grossberg R. Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf. 2005;14:789-793.
19. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41:1569-1582.
20. Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41:1770-1781.
21. Schectman JM, Schorling JB, Nadkarni MM, et al. Can prescription refill feedback to physicians improve patient adherence? Am J Med Sci. 2004;327:19-24.
22. Cote J, Bowie DM, Robichaud P, et al. Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbation. Am J Respir Crit Care Med. 2001;163:1415-1419.
23. Pradier C, Bentz L, Spire B, et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003; 4:121-131.
24. Laporte S, Quenet S, Buchmuller-Cordier A, et al. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost. 2003;89:458-467.
25. Ran MS, Xiang MZ, Chan CL, et al. Effectiveness of psychoeduca-tional intervention for rural Chinese families experiencing schizo-phrenia-a randomised controlled trial. Soc Psychiatry Psychiatr Epidemiol. 2003;38:69-75.
26. Van Wijk BL, Klungel OH, Heerdink ER, et al. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother. 2005;39: 319-328.
27. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-1161.
28. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11:449-457.
29. Cantor A. Extending SAS Survival Analysis Techniques for Medical Research. Cary, NC: SAS Institute, Inc.; 1997.
30. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika. 1986;73:751-754.
31. Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;25:221-228.
32. Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther. 2001;23:970-980.
33. Murray CJ, Kulkarni SC, Michaud C, et al. Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med. 2006;3:e260.
34. U.S. Census Bureau. Census 2000 Data for the State of South Carolina, http://www.census.gov/census2000/states/sc.html. 2007. Accessed October 19, 2007.
35. Antos J. Cutting Through Confusion in Part D. American Enterprise Institute for Public Policy Research; 2006.
36. Campbell MK, Mollison J, Grimshaw JM. Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Stat Med. 2001;20:391-399.